Applied Dna Sciences Inc (NASDAQ:BNBX) Short Interest Down 50.0% in May

Applied Dna Sciences Inc (NASDAQ:BNBX) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 116,017 shares, a decrease of 50.0% from the April 30th total of 231,818 shares. Based on an average daily volume of 58,204 shares, the days-to-cover ratio is presently 2.0 days. Currently, 1.7% of the shares of the stock are short sold.

Applied Dna Sciences Price Performance

Shares of BNBX traded down $0.06 on Wednesday, reaching $0.48. 25,766 shares of the company’s stock were exchanged, compared to its average volume of 604,536. The stock’s 50 day simple moving average is $0.54. Applied Dna Sciences has a 12 month low of $0.35 and a 12 month high of $7.15. The stock has a market cap of $3.46 million, a PE ratio of -0.01 and a beta of 0.52.

Applied Dna Sciences (NASDAQ:BNBX) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.68) earnings per share (EPS) for the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%. The business had revenue of $1.02 million during the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Applied Dna Sciences in a report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Applied Dna Sciences has a consensus rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.